Who owns Q32 Bio Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of QTTB from SEC Form 13F filings across 105 reporting managers. All positions are from one synchronized reporting period — 2026-09-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-09-30 reporting period, 105 institutions disclosed 31.5M shares of Q32 Bio Inc. worth $262.1M — about 92.6% of shares outstanding; the largest disclosed holder is ORBIMED ADVISORS LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
105
13F holders
$262.1M
value, 2026 filers
92.6%
of shares outstanding (31.5M sh)
50
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-09-30 · % of fund = share of the manager's own book · % of co. = share of QTTB's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | ORBIMED ADVISORS LLC | 4.1M | $34.1M | 0.6% | 12.1% | 0.0% |
| 2 | Atlas Venture Life Science Advisors, LLC | 2.7M | $22.5M | 3.6% | 8% | 0.0% |
| 3 | Boxer Capital Management, LLC | 2.6M | $21.3M | 1.9% | 7.6% | -18.2% |
| 4 | BVF INC/IL | 2.4M | $19.4M | 0.6% | 6.9% | 0.0% |
| 5 | RA CAPITAL MANAGEMENT, L.P. | 2.3M | $19.3M | 0.2% | 6.9% | 0.0% |
| 6 | BANK OF AMERICA CORP /DE/NEW | 2.2M | $18.2M | 0.0% | 6.5% | new |
| 7 | PRICE T ROWE ASSOCIATES INC /MD/NEW | 1.5M | $12.4M | 0.0% | 4.4% | new |
| 8 | Opaleye Management Inc. | 1.1M | $9.3M | 1.0% | 3.3% | +20.3% |
| 9 | JPMORGAN CHASE & CONEW | 1.1M | $10.1M | 0.0% | 3.1% | new |
| 10 | VANGUARD CAPITAL MANAGEMENT LLC | 1.0M | $8.3M | 0.0% | 3% | +94.4% |
| 11 | AMERICAN CENTURY COMPANIES INC | 652,597 | $5.4M | 0.0% | 1.9% | +139.3% |
| 12 | CITADEL ADVISORS LLC | 623,395 | $5.2M | 0.0% | 1.8% | +416.6% |
| 13 | BAKER BROS. ADVISORS LPNEW | 547,945 | $4.5M | 0.0% | 1.6% | new |
| 14 | Sio Capital Management, LLCNEW | 529,155 | $4.4M | 0.8% | 1.6% | new |
| 15 | AMERIPRISE FINANCIAL INCNEW | 500,156 | $4.1M | 0.0% | 1.5% | new |
| 16 | SPHERA FUNDS MANAGEMENT LTD.NEW | 448,873 | $3.7M | 0.5% | 1.3% | new |
| 17 | Qube Research & Technologies LtdNEW | 381,469 | $3.2M | 0.0% | 1.1% | new |
| 18 | MARSHALL WACE, LLP | 368,935 | $3.1M | 0.0% | 1.1% | +450.3% |
| 19 | Point72 Asset Management, L.P. | 345,402 | $2.9M | 0.0% | 1% | -70.6% |
| 20 | Ikarian Capital, LLC | 345,000 | $2.9M | 0.3% | 1% | -19.8% |
| 21 | BlackRock, Inc. | 340,353 | $2.8M | 0.0% | 1% | +187.2% |
| 22 | Aberdeen Group plcNEW | 302,500 | $2.5M | 0.0% | 0.9% | new |
| 23 | GOLDMAN SACHS GROUP INCNEW | 288,607 | $2.4M | 0.0% | 0.8% | new |
| 24 | CANTOR FITZGERALD, L. P.NEW | 258,262 | $2.1M | 0.0% | 0.8% | new |
| 25 | MILLENNIUM MANAGEMENT LLC | 248,006 | $2.1M | 0.0% | 0.7% | +2169.5% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.